The BioWorld RNAi Report 2005: Market Developments, Opportunities and Challenges now is available. The book chronicles and forecasts the most talked-about new sector in biotechnology. It provides relevant, concise information for executive-, financial- and scientific-level decision-making.

The RNAi market is in a critical phase as it progresses to clinical trials and is poised for phenomenal growth. RNAi therapeutics are thought to "turn off" the negative function of select genes in cells, thereby preventing disease. The field has enjoyed an eventful beginning, and the report details its history and what's ahead, proffering an in-depth analysis and forecast of the market from 2004 to 2010.

The report addresses the impact of intellectual property litigation, provides clinical trial time tables and a conference calendar, investigates the reagent/research tools market, compares technologies and provides profiles of more than 40 companies involved in RNAi R&D.

For more information please call 1-800-688-2412 or 404-262-5476, or visit www.bioworld.com.

No Comments